Aung Ko Win1, Jeanette C Reece, Shae Ryan. 1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Abstract
OBJECTIVE: To obtain precise estimates of endometrial cancer risk associated with a family history of endometrial cancer or cancers at other sites. DATA SOURCES: For the systematic review, we used PubMed to search for all relevant studies on family history and endometrial cancer that were published before December 2013. Medical Subject Heading terms "endometrial neoplasm" and "uterine neoplasm" were used in combination with one of the key phrases "family history," "first-degree," "familial risk," "aggregation," or "relatedness." METHODS OF STUDY SELECTION: Studies were included if they were case-control or cohort studies that investigated the association between a family history of cancer specified to site and endometrial cancer. Studies were excluded if they were review or editorial articles or not translated into English or did not define family history clearly or used spouses as control participants. TABULATION, INTEGRATION, AND RESULTS: We included 16 studies containing 3,871 women as cases and 49,475 women as controls from 10 case-control studies and 33,510 women as cases from six cohort studies. We conducted meta-analyses to estimate the pooled relative risk (95% confidence interval [CI]) of endometrial cancer associated with a first-degree family history of endometrial, colorectal, breast, ovarian, and cervical cancer to be: 1.82 (1.65-1.98), 1.17 (1.03-1.31), 0.96 (0.88-1.04), 1.13 (0.85-1.41), and 1.19 (0.83-1.55), respectively. We estimated cumulative risk of endometrial cancer to age 70 years to be 3.1% (95% CI 2.8-3.4) for women with a first-degree relative with endometrial cancer and the population-attributable risk to be 3.5% (95% CI 2.8-4.2). CONCLUSION: Women with a first-degree family history of endometrial cancer or colorectal cancer have a higher risk of developing endometrial cancer than those without a family history. This study is likely to be of clinical relevance to inform women of their risk of endometrial cancer.
OBJECTIVE: To obtain precise estimates of endometrial cancer risk associated with a family history of endometrial cancer or cancers at other sites. DATA SOURCES: For the systematic review, we used PubMed to search for all relevant studies on family history and endometrial cancer that were published before December 2013. Medical Subject Heading terms "endometrial neoplasm" and "uterine neoplasm" were used in combination with one of the key phrases "family history," "first-degree," "familial risk," "aggregation," or "relatedness." METHODS OF STUDY SELECTION: Studies were included if they were case-control or cohort studies that investigated the association between a family history of cancer specified to site and endometrial cancer. Studies were excluded if they were review or editorial articles or not translated into English or did not define family history clearly or used spouses as control participants. TABULATION, INTEGRATION, AND RESULTS: We included 16 studies containing 3,871 women as cases and 49,475 women as controls from 10 case-control studies and 33,510 women as cases from six cohort studies. We conducted meta-analyses to estimate the pooled relative risk (95% confidence interval [CI]) of endometrial cancer associated with a first-degree family history of endometrial, colorectal, breast, ovarian, and cervical cancer to be: 1.82 (1.65-1.98), 1.17 (1.03-1.31), 0.96 (0.88-1.04), 1.13 (0.85-1.41), and 1.19 (0.83-1.55), respectively. We estimated cumulative risk of endometrial cancer to age 70 years to be 3.1% (95% CI 2.8-3.4) for women with a first-degree relative with endometrial cancer and the population-attributable risk to be 3.5% (95% CI 2.8-4.2). CONCLUSION:Women with a first-degree family history of endometrial cancer or colorectal cancer have a higher risk of developing endometrial cancer than those without a family history. This study is likely to be of clinical relevance to inform women of their risk of endometrial cancer.
Authors: Piotr Olcha; Anna Winiarska-Mieczan; Małgorzata Kwiecień; Łukasz Nowakowski; Andrzej Miturski; Andrzej Semczuk; Bożena Kiczorowska; Krzysztof Gałczyński Journal: Int J Mol Sci Date: 2022-06-16 Impact factor: 6.208
Authors: Marie T Kumerow; Juan L Rodriguez; Shifan Dai; Katherine Kolor; Melissa Rotunno; Lucy A Peipins Journal: Prev Med Date: 2022-04-20 Impact factor: 4.637
Authors: Maxine M Chen; Tracy A O'Mara; Deborah J Thompson; Jodie N Painter; John Attia; Amanda Black; Louise Brinton; Stephen Chanock; Chu Chen; Timothy Ht Cheng; Linda S Cook; Marta Crous-Bou; Jennifer Doherty; Christine M Friedenreich; Montserrat Garcia-Closas; Mia M Gaudet; Maggie Gorman; Christopher Haiman; Susan E Hankinson; Patricia Hartge; Brian E Henderson; Shirley Hodgson; Elizabeth G Holliday; Pamela L Horn-Ross; David J Hunter; Loic Le Marchand; Xiaolin Liang; Jolanta Lissowska; Jirong Long; Lingeng Lu; Anthony M Magliocco; Lynn Martin; Mark McEvoy; Sara H Olson; Irene Orlow; Loreall Pooler; Jennifer Prescott; Radhai Rastogi; Timothy R Rebbeck; Harvey Risch; Carlotta Sacerdote; Frederick Schumacher; Veronica Wendy Setiawan; Rodney J Scott; Xin Sheng; Xiao-Ou Shu; Constance Turman; David Van Den Berg; Zhaoming Wang; Noel S Weiss; Nicholas Wentzensen; Lucy Xia; Yong-Bing Xiang; Hannah P Yang; Herbert Yu; Wei Zheng; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Douglas F Easton; Peter Kraft; Amanda B Spurdle; Immaculata De Vivo Journal: Hum Mol Genet Date: 2016-03-23 Impact factor: 6.150
Authors: Timothy Ht Cheng; Deborah J Thompson; Tracy A O'Mara; Jodie N Painter; Dylan M Glubb; Susanne Flach; Annabelle Lewis; Juliet D French; Luke Freeman-Mills; David Church; Maggie Gorman; Lynn Martin; Shirley Hodgson; Penelope M Webb; John Attia; Elizabeth G Holliday; Mark McEvoy; Rodney J Scott; Anjali K Henders; Nicholas G Martin; Grant W Montgomery; Dale R Nyholt; Shahana Ahmed; Catherine S Healey; Mitul Shah; Joe Dennis; Peter A Fasching; Matthias W Beckmann; Alexander Hein; Arif B Ekici; Per Hall; Kamila Czene; Hatef Darabi; Jingmei Li; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo Runnebaum; Frederic Amant; Stefanie Schrauwen; Hui Zhao; Diether Lambrechts; Jeroen Depreeuw; Sean C Dowdy; Ellen L Goode; Brooke L Fridley; Stacey J Winham; Tormund S Njølstad; Helga B Salvesen; Jone Trovik; Henrica Mj Werner; Katie Ashton; Geoffrey Otton; Tony Proietto; Tao Liu; Miriam Mints; Emma Tham; Chibcha Consortium; Mulin Jun Li; Shun H Yip; Junwen Wang; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Jonathan P Tyrer; Malcolm Dunlop; Richard Houlston; Claire Palles; John L Hopper; Julian Peto; Anthony J Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jenny Chang-Claude; Fergus J Couch; Graham G Giles; Vessela N Kristensen; Angela Cox; Julie M Cunningham; Paul D P Pharoah; Alison M Dunning; Stacey L Edwards; Douglas F Easton; Ian Tomlinson; Amanda B Spurdle Journal: Nat Genet Date: 2016-05-02 Impact factor: 38.330